Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
An erythropoiesis-stimulating agent (ESA) that treats anemia in chronic kidney disease and chemotherapy patients. It acts by stimulating bone marrow to produce red blood cells, increasing hemoglobin levels and reducing the need for blood transfusions.
| Strength | 60 Mcg |
| Pack | Prefilled Syringe |
| Storage | 2-8°C |
| Uses | To treat anemia associated with chronic kidney disease (CKD) and cancer chemotherapy |
| Main Ingredients | Darbepoetin alfa |